Treatment outcomes and toxicity in patients treated with LDR brachytherapy, single institution study

被引：0
|
作者：
Lukacko, P. [1 ]
机构：
[1] St Elisabeth Oncol Inst, Dep Brachytherapy, Bratislava, Slovakia
来源：
RADIOTHERAPY AND ONCOLOGY | 2021年 / 158卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-0242
引用
收藏
页码：S202 / S202
页数：1
相关论文
共 50 条
  • [1] A Competing Risks Analysis of Clinical Outcomes of Prostate LDR Brachytherapy at a Single Institution
    Edwards, A. A.
    Langley, S. E. M.
    Chadwick, E.
    Javed, S.
    Khaksar, S. J.
    Money-Kyrle, J.
    Laing, R. W.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S415 - S415
  • [2] HDR and LDR brachytherapy in the treatment of paediatric tumours. A single institution experience on 21 patients
    Mazzarotto, R
    Buzzaccarini, MS
    Scarzello, G
    Rigon, A
    Vianello, F
    Cecchetto, G
    Carli, M
    Cillo, U
    Sotti, G
    [J]. RADIOTHERAPY AND ONCOLOGY, 2004, 71 : S135 - S136
  • [3] Retrospective Single Institution Clinical and Radiobiological Review of High Volume Ocular Melanoma Patients Treated with LDR Brachytherapy
    Richards, Z.
    Nguyen, M.
    Firestone, B.
    Kutteh, M.
    Henson, C.
    Ahmad, S.
    Herman, T.
    Herman, T. De La Fuente
    [J]. MEDICAL PHYSICS, 2020, 47 (06) : E845 - E845
  • [4] HDR vs LDR Vaginal brachytherapy: a comparison in terms of outcomes and toxicity
    Autorino, R.
    Smaniotto, D.
    Campitelli, M.
    Tagliaferri, L.
    Nardangeli, A.
    Mattiucci, G.
    Martino, A.
    Di Napoli, N.
    Ferrandina, G.
    Gambacorta, M.
    Valentini, V.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S982 - S982
  • [5] LDR prostate brachytherapy: Clinical outcomes and toxicity at 10 years of follow up in 1300 patients
    Emara, A. M.
    Abdelbaky, A. M.
    Lynch, M.
    Nobes, J.
    Laing, R. W.
    Langley, S. E. M.
    [J]. BJU INTERNATIONAL, 2010, 106 (01) : 4 - 4
  • [6] Dosimetric Outcome of LDR Brachytherapy and Influence on Long-term Tumor Control and Toxicity Outcomes in Patients Treated for Localized Prostate Cancer
    Ashamalla, M.
    Kollmeier, M.
    Cohen, G. N.
    Pei, X.
    Zelefsky, M. J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S383 - S384
  • [7] Interstitial brachytherapy (LDR-brachytherapy) in the treatment of patients with prostate cancer
    Machtens, S
    Karstens, JH
    Baumann, R
    Jonas, U
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (06) : 514 - 521
  • [8] PSA outcomes and late toxicity of single-fraction HDR brachytherapy and LDR brachytherapy as monotherapy in localized prostate cancer: A phase 2 randomized pilot study
    Reynaud, Thomas
    Hathout, Lara
    Carignan, Damien
    Barkati, Maroie
    Martin, Andre-Guy
    Foster, William
    Lacroix, Frederic
    Delouya, Guila
    Taussky, Daniel
    Morton, Gerard
    Vigneault, Eric
    [J]. BRACHYTHERAPY, 2021, 20 (06) : 1090 - 1098
  • [9] Salvage LDR-brachytherapy for recurrent prostate cancer: results from a single institution
    Magrini, S.
    Barbera, F.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S89 - S89
  • [10] A competing-risks analysis of clinical outcomes in a fourteen-year cohort of patients treated with prostate LDR brachytherapy at a single centre
    Edwards, A. A.
    Langley, S. E. M.
    Javed, S.
    Khaksar, S.
    Money-Kyrle, J.
    Laing, R. W.
    [J]. BJU INTERNATIONAL, 2014, 113 : 13 - 13
12345